KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Inventory (2016 - 2026)

Edwards Lifesciences has reported Inventory over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • For Q4 2025, Inventory rose 3.63% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 3.63%, while the annual FY2025 figure was $1.1 billion, 3.63% up from the prior year.
  • Inventory for Q4 2025 was $1.1 billion at Edwards Lifesciences, down from $1.1 billion in the prior quarter.
  • Over five years, Inventory peaked at $1.2 billion in Q1 2024 and troughed at $726.7 million in Q4 2021.
  • A 5-year average of $943.6 million and a median of $947.2 million in 2023 define the central range for Inventory.
  • Biggest five-year swings in Inventory: decreased 9.42% in 2021 and later soared 36.24% in 2023.
  • Year by year, Inventory stood at $726.7 million in 2021, then grew by 20.48% to $875.5 million in 2022, then rose by 3.2% to $903.5 million in 2023, then rose by 20.28% to $1.1 billion in 2024, then grew by 3.63% to $1.1 billion in 2025.
  • Business Quant data shows Inventory for EW at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.